442 related articles for article (PubMed ID: 17653725)
1. [Chloroquine/hydroxychloroquine: variability of retinotoxic cumulative doses].
Rüther K; Foerster J; Berndt S; Schroeter J
Ophthalmologe; 2007 Oct; 104(10):875-9. PubMed ID: 17653725
[TBL] [Abstract][Full Text] [Related]
2. Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy (2016 Revision).
Marmor MF; Kellner U; Lai TY; Melles RB; Mieler WF;
Ophthalmology; 2016 Jun; 123(6):1386-94. PubMed ID: 26992838
[TBL] [Abstract][Full Text] [Related]
3. Regular examinations for toxic maculopathy in long-term chloroquine or hydroxychloroquine users.
Nika M; Blachley TS; Edwards P; Lee PP; Stein JD
JAMA Ophthalmol; 2014 Oct; 132(10):1199-208. PubMed ID: 24970348
[TBL] [Abstract][Full Text] [Related]
4. Retinal toxicity associated with hydroxychloroquine and chloroquine: risk factors, screening, and progression despite cessation of therapy.
Michaelides M; Stover NB; Francis PJ; Weleber RG
Arch Ophthalmol; 2011 Jan; 129(1):30-9. PubMed ID: 21220626
[TBL] [Abstract][Full Text] [Related]
5. [The ERG contribution in early diagnosis of chloroquine and hydroxychloroquine maculopathy].
Karkanová M; Matusková V; Vlková E; Dosková H; Uhmannová R
Cesk Slov Oftalmol; 2010 Apr; 66(2):62-6. PubMed ID: 20925239
[TBL] [Abstract][Full Text] [Related]
6. Detection of early hydroxychloroquine retinal toxicity enhanced by ring ratio analysis of multifocal electroretinography.
Lyons JS; Severns ML
Am J Ophthalmol; 2007 May; 143(5):801-809. PubMed ID: 17336914
[TBL] [Abstract][Full Text] [Related]
7. Multifocal electroretinographic evaluation of long-term hydroxychloroquine users.
Maturi RK; Yu M; Weleber RG
Arch Ophthalmol; 2004 Jul; 122(7):973-81. PubMed ID: 15249360
[TBL] [Abstract][Full Text] [Related]
8. Revised recommendations on screening for chloroquine and hydroxychloroquine retinopathy.
Marmor MF; Kellner U; Lai TY; Lyons JS; Mieler WF;
Ophthalmology; 2011 Feb; 118(2):415-22. PubMed ID: 21292109
[TBL] [Abstract][Full Text] [Related]
9. Long-term course of chloroquine retinopathy after cessation of medication.
Brinkley JR; Dubois EL; Ryan SJ
Am J Ophthalmol; 1979 Jul; 88(1):1-11. PubMed ID: 463998
[TBL] [Abstract][Full Text] [Related]
10. Hydroxychloroquine retinopathy.
Weiner A; Sandberg MA; Gaudio AR; Kini MM; Berson EL
Am J Ophthalmol; 1991 Nov; 112(5):528-34. PubMed ID: 1951589
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of hydroxychloroquine retinopathy with multifocal electroretinography.
So SC; Hedges TR; Schuman JS; Quireza ML
Ophthalmic Surg Lasers Imaging; 2003; 34(3):251-8. PubMed ID: 12757106
[TBL] [Abstract][Full Text] [Related]
12. The Diagnostic Utility of Multifocal Electroretinography in Detecting Chloroquine and Hydroxychloroquine Retinal Toxicity.
Tsang AC; Ahmadi S; Hamilton J; Gao J; Virgili G; Coupland SG; Gottlieb CC
Am J Ophthalmol; 2019 Oct; 206():132-139. PubMed ID: 31078540
[TBL] [Abstract][Full Text] [Related]
13. Electrophysiological and SD-OCT findings in patients receiving chloroquine therapy in relation to cumulative dosage and duration of treatment.
Bertoli F; Šuštar M; Jarc Vidmar M; Perovšek D; Brecelj J; Markelj Š; Jaki Mekjavić P; Šuput D; Tomšič M; Isola M; Battistella C; Lanzetta P; Hawlina M
Doc Ophthalmol; 2020 Aug; 141(1):1-14. PubMed ID: 31927702
[TBL] [Abstract][Full Text] [Related]
14. Comparison of screening procedures in hydroxychloroquine toxicity.
Marmor MF
Arch Ophthalmol; 2012 Apr; 130(4):461-9. PubMed ID: 22159170
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of risk factors for retinal damage due to chloroquine and hydroxychloroquine.
Bergholz R; Schroeter J; Rüther K
Br J Ophthalmol; 2010 Dec; 94(12):1637-42. PubMed ID: 20940312
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Maculopathy in Patients Using Hydroxychloroquine.
Uğurlu A; Aslanova M; Cebeci Z; Kır Mercül N
Turk J Ophthalmol; 2019 Jun; 49(3):149-153. PubMed ID: 31245977
[TBL] [Abstract][Full Text] [Related]
17. [Severe chloroquine- and hydroxychloroquine-induced retinopathy].
Ingster-Moati I; Bui Quoc E; Crochet M; Orssaud C; Dufier JL; Roche O
J Fr Ophtalmol; 2006 Jun; 29(6):642-50. PubMed ID: 16885894
[TBL] [Abstract][Full Text] [Related]
18. Effect of disease stage on progression of hydroxychloroquine retinopathy.
Marmor MF; Hu J
JAMA Ophthalmol; 2014 Sep; 132(9):1105-12. PubMed ID: 24922444
[TBL] [Abstract][Full Text] [Related]
19. [Retinal damage by (hydroxy)chloroquine intake: published evidence for an efficient ophthalmological follow-up].
Pluta JP; Rüther K
Klin Monbl Augenheilkd; 2009 Nov; 226(11):891-6. PubMed ID: 19916149
[TBL] [Abstract][Full Text] [Related]
20. The incidence of irreversible retinal toxicity in patients treated with hydroxychloroquine: a reappraisal.
Mavrikakis I; Sfikakis PP; Mavrikakis E; Rougas K; Nikolaou A; Kostopoulos C; Mavrikakis M
Ophthalmology; 2003 Jul; 110(7):1321-6. PubMed ID: 12867385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
